{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:50:29Z","timestamp":1792788629134,"version":"4.5.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Research Foundation of Korea","award":["RS-2024-00454685"],"award-info":[{"award-number":["RS-2024-00454685"]}],"id":[{"id":"https:\/\/ror.org\/013aysd81","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100014189","name":"Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry","doi-asserted-by":"publisher","award":["RS-2022-IP322009"],"award-info":[{"award-number":["RS-2022-IP322009"]}],"id":[{"id":"10.13039\/501100014189","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Inflammatory bowel disease (IBD) is characterized by chronic inflammation intertwined with fibrosis and increased necroptosis. Vimentin, an intermediate filament protein closely associated with fibrosis and several inflammatory pathways, is elevated in IBD tissues. We conducted experiments to determine the effect of neutralization of extracellular vimentin with an anti-vimentin antibody (Ab) on the pathogenesis of IBD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      IBD was mimicked in a 7-week C57BL6 mice by mixing 3% dextran sodium sulfate (DSS) in autoclaved drinking water for five days.\n                      <jats:bold>A<\/jats:bold>\n                      nti-vimentin Ab was intraperitoneally injected with a concentration of 3 milligrams per kilogram repeatedly in a three-day interval simultaneously with DSS administration.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In dextran sodium sulfate (DSS)-induced colitis mice, the anti-vimentin Ab decreased the levels of total and cell-surface vimentin in colon tissues compared to control-treated mice. In DSS-induced colitis mice, treatment with the anti-vimentin Ab improved body weight loss and colon shortening, thereby reducing the severity of DSS-induced colitis. In addition, the anti-vimentin Ab reduced the number of cells expressing fibrosis markers, inflammatory cytokines, and necroptotic markers in colon tissues of DSS-induced colitis mice. In CCD-18CO human colon epithelial cells, the increases in the levels of fibrosis markers caused by TGF\u03b2 were enhanced by vimentin protein stimulation and the anti-vimentin Ab reduced the levels of fibrosis-related factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This is the first report of the therapeutic effect of an anti-vimentin Ab on the pathogenic mechanisms of IBD. Further studies are needed to confirm its therapeutic potential in clinical settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0352641","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:23:22Z","timestamp":1792517002000},"page":"e0352641","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vimentin neutralizing antibody ameliorate inflammatory bowel disease by inhibiting fibrosis and inflammatory cell death"],"prefix":"10.1371","volume":"21","author":[{"given":"Sol","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Yeon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Sil","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JeongWon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha Yeon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon Yeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8244-374X","authenticated-orcid":true,"given":"Han Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0218-4136","authenticated-orcid":true,"given":"Bo-In","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5715-3989","authenticated-orcid":true,"given":"Mi-La","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"pone.0352641.ref001","doi-asserted-by":"crossref","first-page":"8201672","DOI":"10.1155\/2017\/8201672","article-title":"New frontiers in genetics, gut microbiota, and immunity: a rosetta stone for the pathogenesis of inflammatory bowel disease","volume":"2017","author":"M Zhou","year":"2017","journal-title":"Biomed Res Int"},{"issue":"1","key":"pone.0352641.ref002","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/ibd.20539","article-title":"Intestinal barrier dysfunction in inflammatory bowel diseases","volume":"15","author":"MA McGuckin","year":"2009","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"pone.0352641.ref003","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"TA Wynn","year":"2012","journal-title":"Nat Med"},{"key":"pone.0352641.ref004","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1101\/gad.349358.122","article-title":"Roles of vimentin in health and disease","volume":"36","author":"KM Ridge","year":"2022","journal-title":"Genes Dev"},{"issue":"10","key":"pone.0352641.ref005","doi-asserted-by":"crossref","DOI":"10.3390\/cells7100147","article-title":"Vimentin Diversity in Health and Disease","volume":"7","author":"F Danielsson","year":"2018","journal-title":"Cells"},{"issue":"1","key":"pone.0352641.ref006","doi-asserted-by":"crossref","first-page":"11628","DOI":"10.1038\/s41598-017-12024-z","article-title":"Vimentin knockout results in increased expression of sub-endothelial basement membrane components and carotid stiffness in mice","volume":"7","author":"B Langlois","year":"2017","journal-title":"Sci Rep"},{"key":"pone.0352641.ref007","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.biochi.2022.02.003","article-title":"Vimentin: Regulation and pathogenesis","volume":"197","author":"D Paulin","year":"2022","journal-title":"Biochimie"},{"issue":"5","key":"pone.0352641.ref008","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/gutjnl-2011-301775","article-title":"The intermediate filament protein, vimentin, is a regulator of NOD2 activity","volume":"62","author":"C Stevens","year":"2013","journal-title":"Gut"},{"issue":"11","key":"pone.0352641.ref009","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.4161\/auto.21690","article-title":"A role for vimentin in Crohn disease","volume":"8","author":"P Henderson","year":"2012","journal-title":"Autophagy"},{"key":"pone.0352641.ref010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41421-020-0167-x","article-title":"Inflammasome activation and regulation: toward a better understanding of complex mechanisms","volume":"6","author":"D Zheng","year":"2020","journal-title":"Cell Discov"},{"issue":"13","key":"pone.0352641.ref011","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1091\/mbc.E17-06-0364","article-title":"In wound repair vimentin mediates the transition of mesenchymal leader cells to a myofibroblast phenotype","volume":"29","author":"JL Walker","year":"2018","journal-title":"Mol Biol Cell"},{"issue":"2","key":"pone.0352641.ref012","first-page":"68","article-title":"Cell Surface Vimentin Detection in Cancer Cells by Peptide-Based Monoclonal Antibody","volume":"15","author":"N Sadeghi","year":"2023","journal-title":"Avicenna J Med Biotechnol"},{"issue":"6","key":"pone.0352641.ref013","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2113874119","article-title":"Extracellular vimentin is an attachment factor that facilitates SARS-CoV-2 entry into human endothelial cells","volume":"119","author":"R Amraei","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"pone.0352641.ref014","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/rheumatology\/keq419","article-title":"The relevance of citrullinated vimentin in the production of antibodies against citrullinated proteins and the pathogenesis of rheumatoid arthritis","volume":"50","author":"K Van Steendam","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"pone.0352641.ref015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijid.2022.05.018","article-title":"Serum vimentin predicts mortality in pediatric severe sepsis: A prospective observational study","volume":"121","author":"H Miao","year":"2022","journal-title":"Int J Infect Dis"},{"issue":"585","key":"pone.0352641.ref016","article-title":"Citrullinated vimentin mediates development and progression of lung fibrosis","volume":"13","author":"FJ Li","year":"2021","journal-title":"Sci Transl Med"},{"issue":"1","key":"pone.0352641.ref017","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12964-025-02062-w","article-title":"Extracellular vimentin is a damage-associated molecular pattern protein serving as an agonist of TLR4 in human neutrophils","volume":"23","author":"\u0141 Suprewicz","year":"2025","journal-title":"Cell Commun Signal"},{"issue":"5","key":"pone.0352641.ref018","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3390\/biom13050820","article-title":"The Induction Mechanism of Ferroptosis, Necroptosis, and Pyroptosis in Inflammatory Bowel Disease, Colorectal Cancer, and Intestinal Injury","volume":"13","author":"P Zhou","year":"2023","journal-title":"Biomolecules"},{"issue":"6","key":"pone.0352641.ref019","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.immuni.2005.06.004","article-title":"NOD2 and Crohn\u2019s disease: loss or gain of function?","volume":"22","author":"L Eckmann","year":"2005","journal-title":"Immunity"},{"issue":"14","key":"pone.0352641.ref020","doi-asserted-by":"crossref","first-page":"745","DOI":"10.12998\/wjcc.v6.i14.745","article-title":"Necroptosis in inflammatory bowel disease and other intestinal diseases","volume":"6","author":"S Li","year":"2018","journal-title":"World J Clin Cases"},{"issue":"7364","key":"pone.0352641.ref021","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nature10400","article-title":"Caspase-8 regulates TNF-\u03b1-induced epithelial necroptosis and terminal ileitis","volume":"477","author":"C G\u00fcnther","year":"2011","journal-title":"Nature"},{"issue":"2","key":"pone.0352641.ref022","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3393\/ac.2021.00584.0083","article-title":"Gene and protein expression of epithelial to mesenchymal transition for intestinal and anal fistula: a systematic review","volume":"39","author":"NH Osman","year":"2023","journal-title":"Ann Coloproctol"},{"issue":"5","key":"pone.0352641.ref023","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/gutjnl-2023-329963","article-title":"Fibrosis in IBD: from pathogenesis to therapeutic targets","volume":"73","author":"F Rieder","year":"2024","journal-title":"Gut"},{"issue":"2","key":"pone.0352641.ref024","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/mi.2017.107","article-title":"Epithelial-mesenchymal transition in Crohn\u2019s disease","volume":"11","author":"H Jiang","year":"2018","journal-title":"Mucosal Immunol"},{"issue":"10","key":"pone.0352641.ref025","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/ecco-jcc\/jjw076","article-title":"Fibrotic and Vascular Remodelling of Colonic Wall in Patients with Active Ulcerative Colitis","volume":"10","author":"C Ippolito","year":"2016","journal-title":"J Crohns Colitis"},{"key":"pone.0352641.ref026","doi-asserted-by":"crossref","first-page":"115648","DOI":"10.1016\/j.biopha.2023.115648","article-title":"Therapeutic targeting of vimentin by ALD-R491 impacts multiple pathogenic processes to attenuate acute and chronic colitis in mice","volume":"168","author":"J Wu","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"pone.0352641.ref027","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.3390\/jcm11112961","article-title":"Double-Blind, Randomized, Placebo-Controlled Study on hzVSF-v13, a Novel Anti-Vimentin Monoclonal Antibody Drug as Add-on Standard of Care in the Management of Patients with Moderate to Severe COVID-19","volume":"11","author":"P Prasenohadi","year":"2022","journal-title":"J Clin Med"},{"issue":"11","key":"pone.0352641.ref028","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1002\/jmv.26063","article-title":"Compassionate use of hzVSF-v13 in two patients with severe COVID-19","volume":"92","author":"CK Kang","year":"2020","journal-title":"J Med Virol"},{"issue":"9","key":"pone.0352641.ref029","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.3390\/cells10092321","article-title":"Combination Treatment with the Vimentin-Targeting Antibody hzVSF and Tenofovir Suppresses Woodchuck Hepatitis Virus Infection in Woodchucks","volume":"10","author":"KE Korolowicz","year":"2021","journal-title":"Cells"},{"issue":"7","key":"pone.0352641.ref030","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e07586","article-title":"Humanized virus-suppressing factor inhibits hepatitis B virus infection by targeting viral cell entry","volume":"7","author":"Y Miyakawa","year":"2021","journal-title":"Heliyon"},{"issue":"3","key":"pone.0352641.ref031","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jep.2011.01.022","article-title":"Cordyceps militaris extract suppresses dextran sodium sulfate-induced acute colitis in mice and production of inflammatory mediators from macrophages and mast cells","volume":"134","author":"ES Han","year":"2011","journal-title":"J Ethnopharmacol"},{"key":"pone.0352641.ref032","doi-asserted-by":"crossref","first-page":"862237","DOI":"10.3389\/fcell.2022.862237","article-title":"Vimentin Suppresses Inflammation and Tumorigenesis in the Mouse Intestine","volume":"10","author":"L Wang","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"pone.0352641.ref033","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12876-022-02208-x","article-title":"RIP3 knockdown inhibits necroptosis of human intestinal epithelial cells via TLR4\/MyD88\/NF-\u03baB signaling and ameliorates murine colitis","volume":"22","author":"C Duan","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"pone.0352641.ref034","doi-asserted-by":"crossref","first-page":"669913","DOI":"10.3389\/fmed.2021.669913","article-title":"Rules of Engagement: Epithelial-Microbe Interactions and Inflammatory Bowel Disease","volume":"8","author":"AE Jergens","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"11","key":"pone.0352641.ref035","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.dld.2017.08.017","article-title":"RIP3 AND pMLKL promote necroptosis-induced inflammation and alter membrane permeability in intestinal epithelial cells","volume":"49","author":"A Negroni","year":"2017","journal-title":"Dig Liver Dis"},{"issue":"14","key":"pone.0352641.ref036","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.3390\/ijms22147469","article-title":"Role of Extracellular Vimentin in Cancer-Cell Functionality and Its Influence on Cell Monolayer Permeability Changes Induced by SARS-CoV-2 Receptor Binding Domain","volume":"22","author":"DG Thalla","year":"2021","journal-title":"Int J Mol Sci"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0352641","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:23:28Z","timestamp":1792517008000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0352641"}},"subtitle":[],"editor":[{"given":"Hiroyasu","family":"Nakano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0352641","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]}}}